Literature DB >> 666274

Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge.

A Gjedde, A H Lockwood, T E Duffy, F Plum.   

Abstract

The effects of chronic hyperammonemia on cerebral metabolism were studied in rats four and eight weeks after the construction of a portacaval shunt. Compared to sham-operated controls, shunted animals had increased arterial concentrations of ammonia and glutamine and decreased glutamate. Cerebral blood flow, measured by xenon 133 washout in animals lightly anesthetized with nitrous oxide, increased from a control of 91 +/- 5 (mean +/- SEM) to 139 +/- 20 ml per 100 gm tissue per minute after shunting for eight weeks; however, the cerebral metabolic rate for oxygen was not different from control four or eight weeks after the shunting procedure. Following intraperitoneal administration of a small ammonium acetate load (2.6 mmol/kg), eight-week portacaval animals consistently underwent a fall in cerebral blood flow and cerebral oxygen consumption and developed high-voltage slow waves in the electroencephalogram. Glutamine was produced by the brains of all groups of animals; the cerebral metabolic rate for glutamine was greater than control in eight-week portacaval rats, the only animals to show a net uptake of ammonia into brain. The findings suggest that increased cerebral sensitivity to ammonia, along with nonspecific effects of chronic portal-systemic shunting, may lead to uncoupling of cerebral blood flow and oxidative metabolism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666274     DOI: 10.1002/ana.410030409

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

1.  Effects of porta-systemic shunting and ammonia infusion on cerebral blood flow autoregulation in the rat.

Authors:  Thomas Dethloff; Gitte Moos Knudsen; Bent Adel Hansen; Fin Stolze Larsen
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Effects of simulated upper gastrointestinal hemorrhage on ammonia and related amino acids in blood and brain of chronic portacaval-shunted rats.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; P B Soeters
Journal:  Metab Brain Dis       Date:  1997-06       Impact factor: 3.584

3.  Controversies in ammonia metabolism: implications for hepatic encephalopathy.

Authors:  Alan H Lockwood
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

4.  Hyperammonemia and chronic hepatic encephalopathy: an in vivo PMRS study of the rat brain.

Authors:  D Astore; C A Boicelli
Journal:  MAGMA       Date:  2000-07       Impact factor: 2.310

5.  Organ Distribution of 13N Following Intravenous Injection of [13N]Ammonia into Portacaval-Shunted Rats.

Authors:  Nancy F Cruz; Gerald A Dienel; Patricia A Patrick; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

Review 6.  Pathophysiology of brain edema in fulminant hepatic failure, revisited.

Authors:  A T Blei
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

7.  Effects of chronic exposure to ammonia on glutamate and glutamine interconversion and compartmentation in homogeneous primary cultures of mouse astrocytes.

Authors:  R Huang; G Kala; R K Murthy; L Hertz
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

8.  Intestinal glutamine and ammonia metabolism during chronic hyperammonaemia induced by liver insufficiency.

Authors:  C H Dejong; N E Deutz; P B Soeters
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

Review 9.  Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy.

Authors:  Lasse K Bak; Helle S Waagepetersen; Michael Sørensen; Peter Ott; Hendrik Vilstrup; Susanne Keiding; Arne Schousboe
Journal:  Metab Brain Dis       Date:  2013-01-31       Impact factor: 3.584

10.  Blood-brain barrier transport of L-pipecolic acid in various rat brain regions.

Authors:  A K Charles; Y F Chang; N R Myslinski
Journal:  Neurochem Res       Date:  1983-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.